Welcome to RxBio, Inc.
** BARDA funds development of five drugs to protect against radiation **
A BioTech Start-Up Company based on a Broad Platform of Novel and Proprietary Technology.
RxBio is an early-stage biotechnology company whose near-term focus is the development of novel and proprietary products that protect: a) against lethal whole-body radiation, and b) against damage to the GI tract due to radiation, chemotherapy, and various toxins.
Longer term, the company is focused on the development of novel cancer agents as well as agents that block plaque build-up in blood vessels.
RxBio is dedicated to the discovery, development, and commercialization of its small-molecule platform technology to bring about life-changing therapeutics for mankind.